Log in
Enquire now
Catalent

Catalent

Catalent develops and manufactures drugs, protein-based biologics, cell and gene therapies, and consumer health products.

OverviewStructured DataIssuesContributors

Contents

catalent.com
latam.catalent.com
biologics.catalent.com
Is a
Organization
Organization
Company
Company

Company attributes

Industry
Drug delivery
Drug delivery
Genetic engineering
Genetic engineering
‌
Omega-3 supplement
Dietary supplement
Dietary supplement
Pharmaceutical industry
Pharmaceutical industry
Gene therapy
Gene therapy
Tissue engineering
Tissue engineering
Regenerative medicine
Regenerative medicine
...
Location
Somerset, New Jersey
Somerset, New Jersey
0
Belgium
Belgium
0
Brazil
Brazil
0
China
China
0
Germany
Germany
0
Italy
Italy
0
Japan
Japan
0
Switzerland
Switzerland
0
...
B2X
B2B
B2B
CEO
Alessandro Maselli
Alessandro Maselli
0
AngelList URL
angel.co/company/ca...solutions-1
Pitchbook URL
pitchbook.com/profiles.../60658-12
Legal Name
Catalent, Inc0
Number of Employees (Ranges)
10,001+0
Email Address
solutions@catalent.com
Phone Number
+187758718350
Number of Employees
17,0000
Full Address
14 Schoolhouse Road Somerset, NJ 088730
CIK Number
1,596,7830
Place of Incorporation
Delaware
Delaware
0
IRS Number
208,737,6880
Founded Date
April 2007
0
Competitors
Patheon
Patheon
0
Lonza Group
Lonza Group
0
Baxter International
Baxter International
0
Stock Symbol
CTLT0
Exchange
New York Stock Exchange
New York Stock Exchange
0
Glassdoor ID
43266
Former CEO
John R. Chiminski
John R. Chiminski
0
Patents Assigned (Count)
4
Wellfound ID
catalent-pharma-solutions-1
Country
United States
United States
0
Headquarters
Somerset, New Jersey
Somerset, New Jersey
0

Other attributes

Company Operating Status
Active0
Strategic Partnerships
Virtus Pharmaceuticals
Virtus Pharmaceuticals
0
Overview

Catalent is a US-based company that provides differentiated development and manufacturing solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products. The company works with pharma, biotech, and consumer health companies to optimize those companies' product development, launch, and full life-cycle supply globally. Catalent has expertise in development sciences, delivery technologies, and multi-modality manufacturing, helping companies with personalized medicines, consumer health brand extensions, and blockbuster drugs.

Catalent Corporate Overview (2021)

Catalent is an S&P 500® company that is publicly traded on the New York Stock Exchange under the symbol CTLT. Alessandro Maselli was appointed as president and CEO in July 2022. The company is headquartered in Somerset, New Jersey and reported $4 billion in revenue in its 2021 fiscal year. Catalent has over 17,000 employees worldwide, which includes more than 2,500 scientists and technicians.

Customers

Notable customers include AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Johnson & Johnson, Moderna, Pfizer, and Pierre Fabre.Each year, Catalent helps accelerate over 1,000 partner programs and launch over 150 new products. Its flexible manufacturing platforms at over fifty sites across four continents supply more than 70 billion doses of nearly 7,000 products to over 1,000 customers annually.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like Catalent

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.